Psychiatric Mental Health Diagnosis and Management II
Review with Q&A Grade A (Accurate Answers) -
Maryville.
Q. Med tx is focused on diminishing intrusive thoughts, hyperarousal, and avoidance, with some success and
mixed results
ANSWER
pharmacologic agents for PTSD
Q. Depressive disorder, anxiety disorders, and behavioral problems associated with ______________
ANSWER
PTSD frequent comorbidity
Q. That __________and ______________ are approved by the Food and Drug Administration (FDA) in the treatment
of PTSD in adults, there is scant evidence to support its use for the core symptoms of PTSD in youth
s
ANSWER
ertraline and paroxetine
Q. FDA approval for use in children and adolescents with aggression, severe behavioral dyscontrol, and
severe psychiatric disorders
ANSWER
Risperidone and aripiprazole
Q. Treat dysregulation of the noradrenergic system in adults and youth with PTSD
ANSWER
Antiadrenergic agents
1
,Q. Alpha2-agonists examples
ANSWER
clonidine and guanfacine
Q. Decrease norepinephrine release, such as, are
ANSWER
Alpha2 agonists
Q. Centrally acting β-antagonists example
ANSWER
propranolol
Q. α-1-antagonists example
ANSWER
prazosin
Q. Hypothesized to improve hyperarousal and intrusive thoughts through attenuation of norepinephrine
postsynaptically
ANSWER
propranolol use
Q. Nightmares associated with trauma
ANSWER
prazosin use
Q. Off-label medications including antidepressants, atypical antipsychotics, adrenergic
modulators/sympatholytics, and anticonvulsants/mood stabilizers
ANSWER
Modify PTSD sx
2
, Q. Nightmares and exaggerated startle response: some evidence in adults, but children case report only
ANSWER
clonidine and propanolol
Q. __________ may reduce nightmares in children with PTSD and ____________may diminish symptoms of
reenactment of traumatic events in children
ANSWER
guanfacine and clonidine
Q. Divalproex, carbamazepine, topiramate, and gabapentin have been utilized for adults with PTSD with
modest improvement; some
ANSWER
Mood-stabilizing agents
Q. May provide some relief for the symptoms of hyperarousal, impulsivity, and agitation in young children
with PTSD; in children some evidence
ANSWER
clonidine with dosage ranges of 0.05 to 0.1 mg twice daily
Q. No controlled trials supporting use in children
ANSWER
benzodiazepines
Q. 10-16 treatment sessions, including 9 components itemized in the acronym PRACTICE
ANSWER
Trauma-Focused CBT
Q. Exposure and cognitive reprocessing interventions are paired with directed eye movements, alternating
tones or tapping
ANSWER
EMDR
3